| Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of ... - Welt Online |
|
|
Welt OnlineUse caution and monitor patients when administering FOLOTYN to patients with moderate to severe renal function impairment. Elevated liver function test ... read more |